The 2020 installment of our day-and-a-half valve disease CME series will be available to more cardiovascular specialists than ever thanks to a complimentary livestream offering.
Patients undergoing mitral valve surgery for radiation-associated cardiac disease have five-year survival of just 55% in a new analysis, dramatically lower than rates in other mitral valve surgery cohorts.
Researchers draw from a large retrospective review to visually show how sex-related differences in the causes of surgically treated mitral valve disease have persisted over the past quarter century.
Conference to provide expert advice from world leaders on the symptoms, treatments and outcomes of Shone’s complex, a rare and complicated congenital heart abnormality.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
Robotic and catheter-based techniques promise to make mitral valve repair and replacement less invasive than ever. But how effective are they, and are robotic approaches ready to go mainstream?